16 CFR § 456.3 - Verifiable affirmative consent to providing the prescription in a digital format.
---
identifier: "/us/cfr/t16/s456.3"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "16 CFR § 456.3 - Verifiable affirmative consent to providing the prescription in a digital format."
title_number: 16
title_name: "Commercial Practices"
section_number: "456.3"
section_name: "Verifiable affirmative consent to providing the prescription in a digital format."
chapter_name: "FEDERAL TRADE COMMISSION"
subchapter_number: "D"
subchapter_name: "TRADE REGULATION RULES"
part_number: "456"
part_name: "OPHTHALMIC PRACTICE RULES (EYEGLASS RULE)"
positive_law: false
currency: "2026-03-24"
last_updated: "2026-03-24"
format_version: "1.1.0"
generator: "[email protected]"
authority: "15 U.S.C. 57a."
regulatory_source: "57 FR 18822, May 1, 1992, unless otherwise noted."
cfr_part: "456"
---
# 456.3 Verifiable affirmative consent to providing the prescription in a digital format.
For a prescription copy provided in a digital format, the prescriber shall:
(a) Identify to the patient the specific method or methods of electronic delivery that will be used, such as text message, electronic mail, or an online patient portal;
(b) Obtain, on paper or in a digital format, the patient's verifiable affirmative consent to receive a digital copy through the identified method or methods; and
(c) Maintain records or evidence of a patient's affirmative consent for a period of not less than three years. Such records or evidence shall be available for inspection by the Federal Trade Commission, its employees, and its representatives.
[89 FR 60774, July 26, 2024]